Plasma cell biology

Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma

Aktas Samur A, Corre J, Talluri S, …, Szalat R, …, Samur MK

Journal of Clinical Oncology44(4):321-334DOI: Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple MyelomaPubMed: Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma

Hepatic response criteria in light chain amyloidosis: a multicenter validation study

Muchtar E, Palladini G, Schonland S, …, Szalat R, …, Gertz MA

HaematologicaDOI: Hepatic response criteria in light chain amyloidosis: a multicenter validation studyPubMed: Hepatic response criteria in light chain amyloidosis: a multicenter validation study

Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis

Muchtar E, Wisniowski B, Geyer S, …, Szalat R, …, Gertz MA

JAMA Oncology10(10):1362DOI: Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain AmyloidosisPubMed: Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis

Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis

Muchtar E, Dispenzieri A, Wisniowski B, …, Szalat R, …, Gertz MA

Journal of Clinical Oncology41(7):1393-1403DOI: Graded Cardiac Response Criteria for Patients With Systemic Light Chain AmyloidosisPubMed: Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis

Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

Gustine JN, Szalat RE, Staron A, Joshi T, Mendelson L, Sloan JM, Sanchorawala V

Haematologica108(6):1680-1684DOI: Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomesPubMed: Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Bazarbachi AH, Avet-Loiseau H, Szalat R, …, Samur MK

Blood138(20):1980-1985DOI: IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WMPubMed: IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Maura F, Petljak M, Lionetti M, …, Szalat R, …, Bolli N

Leukemia32(4):1043-1047DOI: Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell linesPubMed: Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease

Cohen C, Royer B, Javaugue V, Szalat R, …, Bridoux F

Kidney International88(5):1135-1143DOI: Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition diseasePubMed: Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease

Single-cell transcriptomics of AL amyloidosis reveals pathogenic mechanisms, immune interactions and altered clonal and polyclonal plasma cell phenotypes

Smith J, Samur M, Talluri S, …, Szalat R

Blood146(Supplement 1):3923-3923DOI: Single-cell transcriptomics of AL amyloidosis reveals pathogenic mechanisms, immune interactions and altered clonal and polyclonal plasma cell phenotypes

Bone marrow plasma cells and immune microenvironment transcriptomic architecture in AL amyloidosis during daratumumab based therapy

Szalat R, Talluri S, Wong S, Morgan G, Sanchorawala V, Munshi N, et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS31:S176-S176

Clinical Characteristics and Therapeutic Response of Patients with Heavy Chain (AH) and Heavy and Light Chain (AHL) Amyloidosis

Li KY, Staron A, Sanchorawala V, Szalat RE

Blood144(Supplement 1):3303-3303DOI: Clinical Characteristics and Therapeutic Response of Patients with Heavy Chain (AH) and Heavy and Light Chain (AHL) Amyloidosis

Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study

Muchtar E, Palladini G, Schonland S, …, Szalat RE, …, Gertz MA

Blood142(Supplement 1):3411-3411DOI: Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study

When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Abdallah M, Arters F, Patel J, …, Szalat RE

Blood142(Supplement 1):7432-7432DOI: When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Graded Renal Response Criteria for Light Chain (AL) Amyloidosis

Muchtar E, Wisniowski B, Palladini G, …, Szalat R, …, Gertz MA

Blood138(Supplement 1):2721-2721DOI: Graded Renal Response Criteria for Light Chain (AL) Amyloidosis

OAB-036: Graded renal response criteria and revised renal progression criteria for light chain (AL) amyloidosis

Muchtar E, Wisniowski B, Palladini G, …, Szalat R, …, Gertz M

Clinical Lymphoma Myeloma and Leukemia21:S23-S24DOI: OAB-036: Graded renal response criteria and revised renal progression criteria for light chain (AL) amyloidosis

Genomic and Transcriptomic Characterization of IgM Multiple Myeloma Identifies a Pre-Germinal Center Plasma Cell Disorder with Immature B-Cell Transcription-Factor Signature

Bazarbachi AH, Avet-Loiseau H, Hunter ZR, Szalat R, …, Munshi NC

Blood136(Supplement 1):7-8DOI: Genomic and Transcriptomic Characterization of IgM Multiple Myeloma Identifies a Pre-Germinal Center Plasma Cell Disorder with Immature B-Cell Transcription-Factor Signature